{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:27:46Z","timestamp":1788895666717,"version":"build-2803163510"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>The experience with uterine inflammatory myofibroblastic neoplasms with an unfavorable outcome is limited. We present the clinicopathologic features of 9 such cases, including 8 inflammatory myofibroblastic tumors (IMTs) and 1 epithelioid inflammatory myofibroblastic sarcoma (EIMS). Median patient age for the IMT group was 50.5 years; the patient with EIMS was 43 years old. Patients presented with abnormal uterine bleeding, presumed fibroids, pelvic pain, arthralgia and low-grade fever, as well as an incidental finding. Median tumor size for the IMTs was 8.5\u2009cm. The borders were either infiltrative or well-circumscribed. Histologically, IMTs were purely fascicular or myxoid or showed predominance of one or the other pattern. Seven tumors were spindled, and 1 was both spindled and epithelioid. Tumors had variable nuclear atypia, ranging from grade 1 to 3. All tumors had an inflammatory infiltrate-predominantly lymphocytic, majority had necrosis (62.5%) and none had lymphovascular invasion. 7\/8 (87.5%) tumors were positive for ALK-1 by immunohistochemistry (IHC). One tumor was negative for ALK-1 by IHC but was positive for <jats:italic toggle=\"yes\">ALK<\/jats:italic> fusion by fluorescence in situ hybridization and had <jats:italic toggle=\"yes\">TNS1-ALK<\/jats:italic> fusion by next-generation sequencing (NGS). Three other tumors with NGS testing showed one of the following <jats:italic toggle=\"yes\">ALK<\/jats:italic>-fusion partners: <jats:italic toggle=\"yes\">FN1<\/jats:italic>, <jats:italic toggle=\"yes\">DCTN1<\/jats:italic>, and <jats:italic toggle=\"yes\">IGFBP5.<\/jats:italic> The EIMS had infiltrative borders, myxoid and hyalinized patterns, epithelioid cells, and no lymphovascular invasion. This tumor was ALK-1 positive by IHC, had <jats:italic toggle=\"yes\">ALK<\/jats:italic> rearrangement by fluorescence in situ hybridization and <jats:italic toggle=\"yes\">RANBP2-ALK<\/jats:italic> fusion by NGS. Extrauterine disease at time of diagnosis was noted in 2\/8 (25%) of IMTs, and in the single case of EIMS. Seven patients had surgery as primary treatment, 1 patient had neoadjuvant chemotherapy and 1 patient declined treatment. Patients with recurrence were treated with a combination of chemotherapy, targeted therapy, radiotherapy or hormonal therapy. Most patients (71.4%) recurred within 24 months (mos). Two thirds of patients were alive with disease at last follow up (mean 43.6\u2009mos). The patient with EIMS was alive with disease at 22 mos. IMT referral cases were initially diagnosed as smooth muscle tumors in 87.5% of cases; while the EIMS was diagnosed as high-grade endometrial stromal sarcoma. Lack of consideration of IMT in the differential diagnosis of smooth muscle tumors with myxoid features can result in misdiagnosis and under-utilization of targeted therapy in these patients.<\/jats:p>","DOI":"10.1097\/pas.0000000000001756","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T20:01:34Z","timestamp":1623960094000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":53,"title":["Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Katrina","family":"Collins","sequence":"first","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Ramalingam","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Euscher","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Reques Llanos","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0000000000001525","article-title":"Inflammatory myofibroblastic tumor of the uterus: an immunohistochemical study of 23 cases","volume":"44","author":"Bennett","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","article-title":"Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases","volume":"19","author":"Coffin","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","article-title":"Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: a low threshold for ALK immunohistochemistry is required","volume":"41","author":"Pickett","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1067\/S0002-9378(03)00208-4","article-title":"Inflammatory myoblastic tumor of the uterus and interleukin-6","volume":"189","author":"Azuno","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R7-20250608","first-page":"412","article-title":"Inflammatory myofibroblastic tumor of uterus: report of a case","volume":"41","author":"Dong","year":"2012","journal-title":"Zhonghua Bing Li Xue Za Zhi [Chinese Journal of Pathology]"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fped.2020.00036","article-title":"Inflammatory myofibroblastic tumors in the uterus: childhood-case report and review of the literature","volume":"8","author":"Etlinger","year":"2020","journal-title":"Front Pediatr"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"623","DOI":"10.5858\/arpa.2011-0341-OA","article-title":"ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract","volume":"136","author":"Fuehrer","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004347-198709000-00008","article-title":"Inflammatory pseudotumor of the uterus","volume":"6","author":"Gilks","year":"1987","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejogrb.2011.01.002","article-title":"Inflammatory pseudotumor of uterus: an unusual pelvic mass","volume":"156","author":"Gupta","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1","volume":"41","author":"Haimes","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/030089169508100615","article-title":"Inflammatory pseudotumor of the uterus: a case report","volume":"81","author":"Kargi","year":"1995","journal-title":"Tumori"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gynor.2013.07.007","article-title":"Extrauterine inflammatory myofibroblastic tumor: a case report","volume":"6","author":"Kushnir","year":"2013","journal-title":"Gynecol Oncol Case Rep"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5644\/ama2006-124.248","article-title":"TNS1-ALK fusion in a recurrent, metastatic uterine mesenchymal tumor originally diagnosed as leiomyosarcoma","volume":"48","author":"Lee","year":"2019","journal-title":"Acta Med Acad"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"e8974","DOI":"10.1097\/MD.0000000000008974","article-title":"Uterine inflammatory myofibroblastic tumor: more common than expected: case report and review","volume":"96","author":"Mandato","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/PAS.0000000000001120","article-title":"ALK is a specific diagnostic marker for inflammatory myofibroblastic tumor of the uterus","volume":"42","author":"Mohammad","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejogrb.2011.02.016","article-title":"Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review","volume":"157","author":"Olgan","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","article-title":"Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course","volume":"39","author":"Parra-Herran","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAS.0000000000000593","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms","volume":"40","author":"Parra-Herran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/01.pas.0000172189.02424.91","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors","volume":"29","author":"Rabban","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-3468(88)80419-6","article-title":"Inflammatory pseudotumors in children","volume":"23","author":"Scott","year":"1988","journal-title":"J Pediatr Surg"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1440-1827.2006.02018.x","article-title":"Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change","volume":"56","author":"Shintaku","year":"2006","journal-title":"Pathol Int"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-015-0160-2","article-title":"STUMP un\u201cstumped\u201d: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion","volume":"8","author":"Subbiah","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1177\/0300060518780873","article-title":"Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report","volume":"46","author":"Takahashi","year":"2018","journal-title":"J Int Med Res"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/PGP.0000000000000588","article-title":"Uterine inflammatory myofibroblastic tumor showing an atypical ALK signal pattern by FISH and DES-ALK fusion by RNA sequencing: a case report","volume":"39","author":"Zarei","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.pathol.2020.01.222","article-title":"Uterine inflammatory myofibroblastic tumor: a case report","volume":"52","author":"Butler","year":"2020","journal-title":"Pathology"},{"key":"R29-20250608","first-page":"115","article-title":"Aggressive uterine inflammatory myofibroblastic tumors have pathogenic molecular alterations in addition to ALK fusions","volume":"32","author":"Therrien","year":"2019","journal-title":"Mod Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00004347-199401000-00010","article-title":"Inflammatory pseudotumor of the cervix","volume":"13","author":"Abenoza","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1200\/JCO.2013.48.8304","article-title":"Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass","volume":"33","author":"Fraggetta","year":"2015","journal-title":"J Clin Oncol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2005.05.021","article-title":"Invasive inflammatory pseudotumor of uterine cervix: a case report","volume":"98","author":"Gucer","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/pbc.22391","article-title":"Radiological appearance of inflammatory myofibroblastic tumour","volume":"54","author":"Rasalkar","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpag.2007.05.006","article-title":"Ovarian inflammatory myofibroblastic tumor in children","volume":"20","author":"Sahnoun","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PGP.0000000000000175","article-title":"Inflammatory myofibroblastic tumor of the placenta: a report of a novel lesion in 2 patients","volume":"34","author":"Banet","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/PGP.0000000000000323","article-title":"ALK-rearranged inflammatory myofibroblastic tumor of the placenta, with observations on site of origin","volume":"36","author":"Schoolmeester","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0000000000001044","article-title":"Inflammatory myofibroblastic tumor associated with the placenta: short tandem repeat genotyping confirms uterine site of origin","volume":"42","author":"Ladwig","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2020.09.005","article-title":"Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases","volume":"106","author":"Makhdoum","year":"2020","journal-title":"Hum Pathol"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.03.014","article-title":"Uterine inflammatory myofibroblastic tumor involving the decidua of the extraplacental membranes: report of a case with a TIMP3-ROS1 gene fusion","volume":"100","author":"Schoolmeester","year":"2020","journal-title":"Hum Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pathol.2018.05.008","article-title":"ALK-rearranged inflammatory myofibroblastic tumour of placental membranes","volume":"50","author":"Squires","year":"2018","journal-title":"Pathology"},{"key":"R42-20250608","first-page":"767","article-title":"Inflammatory pseudotumor (plasma cell granuloma) of the pelvic cavity. A case report","volume":"47","author":"Ben-Aroya","year":"2002","journal-title":"J Reprod Med"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PGP.0000000000000505","article-title":"Inflammatory myofibroblastic tumor arising in the cul-de-sac, mimicking ectopic decidua","volume":"38","author":"Ioannidis","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.gore.2015.01.007","article-title":"Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: a case report and review of the literature","volume":"12","author":"Kim","year":"2015","journal-title":"Gynecol Oncol Rep"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/PGP.0000000000000431","article-title":"Epithelioid inflammatory myofibroblastic sarcoma of the ovary with RANB2-ALK fusion: report of a case","volume":"37","author":"Fang","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Marino-Enriquez","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PAS.0000000000001167","article-title":"Morphologic overlap between inflammatory myofibroblastic tumor and IgG4-related disease: lessons from next-generation sequencing","volume":"43","author":"Taylor","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1072-7515(02)01495-3","article-title":"Inflammatory pseudotumor of the liver: demographics, diagnosis, and the case for nonoperative management","volume":"196","author":"Koea","year":"2003","journal-title":"J Am Coll Surg"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5858\/2001-125-0379-SIMTIP","article-title":"Splenic inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunophenotypic study of 12 cases","volume":"125","author":"Neuhauser","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/jjco\/hyu069","article-title":"A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib","volume":"44","author":"Kimbara","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00000478-200111000-00003","article-title":"Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study","volume":"25","author":"Cook","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAP.0000000000000164","article-title":"Myxoid mesenchymal tumors of the uterus: an update on classification, definitions, and differential diagnosis","volume":"24","author":"Busca","year":"2017","journal-title":"Adv Anat Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:06:00Z","timestamp":1749416760000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001756"}},"subtitle":["A Clinicopathologic Study of 9 Cases"],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001756","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,17]]}}}